Sourcing your starting material from healthy, high-quality donors matters when
you are manufacturing an allogeneic cell therapy. Any misstep can mean delays
in your therapy’s development.
Keep these key considerations top of mind as you evaluate whether potential
partners have the experience, expertise and relationships required to identify, source and collect your allogeneic donors and deliver the starting material for manufacture.